Lupus anticoagulant and anticardiolipin antibodies in polytransfused beta thalassemia major

Hematology

Volumn 11, Issue 4, 2006, Pages 287-290

  Sharma, Sunita ^a   Raina, Vineeta ^a   Chandra, Jagdish ^a   Narayan, Shashi ^a   Sharma, Siddharth ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

Anticardiolipid antibodies; Beta thalassemia; Lupus anticoagulant; Therapeutics

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; AGE; ANTIBODY DETECTION; ARTICLE; BLEEDING TENDENCY; BLOOD CLOTTING; BLOOD TRANSFUSION; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; ECCHYMOSIS; HEMATOLOGICAL PARAMETERS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THALASSEMIA MAJOR; THROMBOCYTE COUNT; THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, ANTICARDIOLIPIN; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; HEMORRHAGIC DISORDERS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS COAGULATION INHIBITOR; MALE; PARTIAL THROMBOPLASTIN TIME; SPLENECTOMY; THROMBOCYTOPENIA; THROMBOPHILIA;

EID: 33845703857     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330600954130     Document Type: Article

References (14)

1. Eldor, A and Maclouf, J and Lellouche, F and Ben Yashar, V and (1993) A chronic hypercoagulable state and lifelong platelet activation in beta thalassemia major Southeast Asian J Trop Med Public Health, 24(Suppl), pp. 92-95.
2. Eldor, A and Kraust, Y and Allan, H and Snyde, D and Goldfarb, A and (1993) Platelet survival in patients with beta thalassemia Am J Hematol, 44, pp. 63-65.
3. Helley, D and Eldor, A and Girot, R and Ducrocq, R and Guillin, M and (1996) Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta thalassemia Thromb Haemost, 76, pp. 322-327.
4. Ruf, A and Pick, M and Deutsch, V and Patsheke, H and Goldfarb, A and (1997) In vivo platelet activation correlates with red cell anionic phospholipids exposure in patients with beta-thalassemia major Br J Hematol, 98, pp. 51-56.
5. Andrew, M and Manno, M and Karpatkin, M. (1998) Demonstration of Kallikrein-like protaease activity in nonactivated plasma of patients with Cooley's anemia Blood, 61, pp. 232-237.
6. Sinniah, D and Bosco, T and Kamaruddin, A. (1984) Prednisolone therapy for lupus anticoagulant in beta thalassemia major Singapore Med J, 25, pp. 77-79.
7. Ibrahim, CP. (1999) Haemostatic derangements and lupus anticoagulant in polytransfused patients of β-thalassemia major Asian J Paediatr Pract, 3, pp. 31-38.
8. Hejmadi, A.(1997) Study of coagulation profile: Role of lupus anticoagulant in multitransfused thalassemic children. In Abstracts of 34th national conference of Indian academy of paediatrics. (pp. 84-85).
9. Giordano, P and Galli, M and Del Vecchio, GL and Altomare, M and Ruggere, L and (1998) Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassemia Br J Hematol, 102, pp. 903-906.
10. Moratelli, S and Sanctis, V and Gemmati, D and Serino, MC and Mari, R and Gamberini, MR and Scapoli, GL. (1998) Thrombotic risk in thalassemic patients J Pediatr Endocrinol Metab, 11, pp. 915-921.
11. Mondher Z, Herthem CM, Sondes M, et al. Lupus anticoagulant, anticardiolipin antibodies and anti beta2 GPI antibodies in patients witht thalassemia Poster presentation in APS-X. International Congress on antiphospholipid antibodies Sicily, Italy. Sep. 29-Oct. 3, 2002.
12. Sinniah, D and Ekert, H and Bosco, J and Nalhern, L and Koe, SL. (1981) Intracranial haemorrhage and circulating coagulation inhibitor in beta thalassemia major J Paediatr, 99, pp. 700-703.
13. Schlerder, MA and Nachman, RL and Jaffe, EA and Coleman, MA. (1976) A clinical study of lupus anticoagulant Blood, 48, pp. 499-509.
14. Hunt, JE and Mc Neil, HP and Morgan, GJ and Crameri, RM and Krillis, SA. (1992) A phospholipids-beta-2-GPI complex is antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection Lupus, 1(20), pp. 75-81.